The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(2E)-2-[(Benzyloxy)imino]-3-(4-hydroxyphenyl)-N-[(4-sulfamoylphenyl)methyl]propanamide ID: ALA4483677
PubChem CID: 155540629
Max Phase: Preclinical
Molecular Formula: C23H23N3O5S
Molecular Weight: 453.52
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: NS(=O)(=O)c1ccc(CNC(=O)/C(Cc2ccc(O)cc2)=N/OCc2ccccc2)cc1
Standard InChI: InChI=1S/C23H23N3O5S/c24-32(29,30)21-12-8-18(9-13-21)15-25-23(28)22(14-17-6-10-20(27)11-7-17)26-31-16-19-4-2-1-3-5-19/h1-13,27H,14-16H2,(H,25,28)(H2,24,29,30)/b26-22+
Standard InChI Key: CHLLBTSJOUDGTR-XTCLZLMSSA-N
Molfile:
RDKit 2D
32 34 0 0 0 0 0 0 0 0999 V2000
46.5758 -22.0807 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
46.1713 -21.3749 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
45.7623 -22.0781 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
39.8098 -17.6975 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.8087 -18.5171 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.5167 -18.9260 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.2264 -18.5166 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.2236 -17.6939 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.5149 -17.2887 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.5165 -19.7432 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.2241 -20.1520 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.2239 -20.9692 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
40.5161 -21.3776 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
41.9319 -19.7436 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.6396 -20.1523 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
41.9321 -18.9264 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
43.3474 -19.7439 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.0550 -20.1527 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.0511 -20.9674 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.7579 -21.3761 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
45.4667 -20.9676 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
45.4642 -20.1462 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.7569 -19.7412 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
46.8792 -20.9667 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
40.5125 -16.4715 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
39.8085 -20.9688 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.1007 -21.3772 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.3952 -20.9673 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.6879 -21.3750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.6873 -22.1931 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.3999 -22.6017 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.1043 -22.1916 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
6 10 1 0
10 11 1 0
11 12 2 0
12 13 1 0
11 14 1 0
14 15 1 0
14 16 2 0
15 17 1 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 18 1 0
21 2 1 0
2 24 1 0
9 25 1 0
13 26 1 0
26 27 1 0
27 28 2 0
28 29 1 0
29 30 2 0
30 31 1 0
31 32 2 0
32 27 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 453.52Molecular Weight (Monoisotopic): 453.1358AlogP: 2.47#Rotatable Bonds: 9Polar Surface Area: 131.08Molecular Species: NEUTRALHBA: 6HBD: 3#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 4#RO5 Violations (Lipinski): ┄CX Acidic pKa: 9.42CX Basic pKa: ┄CX LogP: 3.46CX LogD: 3.45Aromatic Rings: 3Heavy Atoms: 32QED Weighted: 0.34Np Likeness Score: -0.66
References 1. Mujumdar P, Kopecka J, Bua S, Supuran CT, Riganti C, Poulsen SA.. (2019) Carbonic Anhydrase XII Inhibitors Overcome Temozolomide Resistance in Glioblastoma., 62 (8): [PMID:30925064 ] [10.1021/acs.jmedchem.9b00282 ]